AMUNNI, GIANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.167
EU - Europa 2.918
AS - Asia 1.063
SA - Sud America 153
OC - Oceania 27
AF - Africa 25
Totale 7.353
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.147
PL - Polonia 1.060
RU - Federazione Russa 721
IT - Italia 382
SG - Singapore 309
CN - Cina 263
SE - Svezia 226
HK - Hong Kong 203
IE - Irlanda 157
BR - Brasile 128
KR - Corea 108
DE - Germania 104
UA - Ucraina 89
FI - Finlandia 56
VN - Vietnam 52
GB - Regno Unito 51
FR - Francia 41
IN - India 32
AU - Australia 25
JO - Giordania 19
TR - Turchia 17
ID - Indonesia 16
AR - Argentina 14
CA - Canada 14
BD - Bangladesh 10
CH - Svizzera 8
JP - Giappone 8
CI - Costa d'Avorio 7
NL - Olanda 7
ZA - Sudafrica 6
ES - Italia 5
SC - Seychelles 5
BE - Belgio 4
IQ - Iraq 4
CO - Colombia 3
EG - Egitto 3
MX - Messico 3
PH - Filippine 3
PY - Paraguay 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
CZ - Repubblica Ceca 2
DZ - Algeria 2
GE - Georgia 2
IL - Israele 2
LT - Lituania 2
NP - Nepal 2
PE - Perù 2
UY - Uruguay 2
AT - Austria 1
AZ - Azerbaigian 1
BJ - Benin 1
BO - Bolivia 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KI - Kiribati 1
LK - Sri Lanka 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
PW - Palau 1
QA - Qatar 1
RO - Romania 1
TH - Thailandia 1
Totale 7.353
Salva come PNG Salva come JPEG
Città #
Warsaw 1.060
Santa Clara 862
Ashburn 289
Fairfield 258
Chandler 218
Singapore 210
Hong Kong 171
Dublin 157
Jacksonville 153
Woodbridge 150
Seoul 108
Houston 102
Seattle 94
Wilmington 89
Cambridge 85
Beijing 69
Hefei 67
Buffalo 49
Altamura 44
Lawrence 44
Ann Arbor 41
Princeton 41
Los Angeles 37
San Jose 32
Milan 31
Moscow 31
Boardman 30
Medford 29
Munich 29
Paris 28
Council Bluffs 26
Melbourne 25
Boston 24
Shanghai 23
The Dalles 22
Mumbai 18
Dong Ket 16
San Diego 16
Florence 15
Rome 15
Izmir 13
Turku 13
Bari 12
Ho Chi Minh City 12
Jakarta 12
New York 11
Dallas 10
Hanoi 10
Kent 10
São Paulo 10
Toronto 10
Norwalk 8
Salerno 8
Abidjan 7
Belo Horizonte 7
Helsinki 7
Tokyo 7
Bern 6
Genoa 6
Rio de Janeiro 6
Curitiba 5
Frankfurt Am Main 5
Hillsboro 5
London 5
San Francisco 5
Tianjin 5
Verona 5
Brooklyn 4
Catania 4
Phoenix 4
Pontedera 4
Portoferraio 4
Torregrotta 4
Viareggio 4
West Jordan 4
Yubileyny 4
Amman 3
Andover 3
Aversa 3
Bengaluru 3
Bozzolo 3
Brussels 3
Campinas 3
Clifton 3
Düsseldorf 3
Elk Grove Village 3
Erba 3
Frankfurt am Main 3
Guangzhou 3
Johannesburg 3
Monsummano Terme 3
Montreal 3
Orem 3
Pistoia 3
Scandicci 3
Siena 3
Siracusa 3
Stagno 3
Amsterdam 2
Aracaju 2
Totale 5.134
Salva come PNG Salva come JPEG
Nome #
C-kit expression in uterine leiomyosarcomas: an immunocytochemical study of 29 cases of malignant smooth muscle tumors of the uterus. 323
EXPRESSION OF INDUCILE NITRIC OXIDE SYNTHASE AND CYCLOOXYGENASE-2 IN OVARIAN CANCER: CORRRELATION WITH CLINICAL OUTCOME 315
C-KIT EXPRESSION AND CORRELATION WITH CHEMOTERAPY RESISTANCE IN OVARIAN CARCINOMA: AN IMMUNOCYTOCHEMICAL STUDY 315
Raccomandazioni cliniche per il carcinoma mammario 304
THE USE OF INTRAVENOUS METHOTREXATE IN THE TREATMENT OF ECTOPIC PREGNANCY 293
Multidrug resistance in ovarian cancer: comparing an immunocytochemical study and ATP-tumor chemosensitivity assay. 292
Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma. 279
Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas. 247
Utility of CDX-2 in distinguishing between primary and secondary (intestinal) mucinous ovarian carcinoma: an immunohistochemical comparison of 43 cases. 247
Aspetti psicosociali dell’adattamento alla malattia in pazienti oncologiche 198
EPITHELIAL OVARIAN TUMORS IN THE REPRODUCTIVE AGE GROUP: AGE IS NOT AN INDEPENDENT PROGNOSTIC FACTOR 183
Stable disease in a patient with metastatic leiomyosarcoma treated with trabectedin 182
Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors 174
Assessing psychological needs in female cancer patients: A tailored model 173
Uterine sarcoma: twenty-seven years of experience. 172
COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies? 170
Estrogen and progesterone receptors expression in uterine malignant smooth muscletumors: correlation with clinical outcome. 165
Treatment of uterine sarcoma at the University of Florence from 1980-2001. 162
Cyclooxygenase-2, angiogenesis, tumor cell proliferation, P-glycoprotein in advanced ovarian serous carcinoma 159
THE PROTOONCOGENE C-KIT IS EXPRESSED IN LEIOMYOSARCOMAS OF THE UTERUS 158
Retrospective analysis of 77 patients with ovarian cancer undergoing genetic testing for BRCA1 and BRCA2 mutations 157
Microvessel density in ovarian carcinoma: computer image analysis in patients with shorter and longer survival. 155
Early life events and gynaecological cancer: a pilot study 154
Expression and amplification of HER-2/neu oncogene in uterine carcinosarcomas: a marker for potential molecularly targeted treatment? 154
Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value? 153
Vaginal hysterectomy and abdominal hysterectomy for treatment of endometrial cancer in the elderly 151
COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates. 148
Cyclooxygenase-2 expression in uterine leiomyosarcomas. 141
HER-2/neu and bcl-2 in ovarian carcinoma: clinicopathologic, immunohistochemical, and molecular study in patients with shorter and longer survival. 136
Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards 133
[Bcl-2 in ovarian carcinoma: a clinicopathologic, immunohistochemical and molecular study]. 131
Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: DNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors. 128
Ovarian cancer in the elderly: feasibility of surgery and chemotherapy in 89 geriatric patients. 127
Preoperative evaluation of tumor ploidy in endometrial carcinoma - An accurate tool to identify patients at risk for extrauterine disease and recurrence 124
Polychemotherapy in ovarian cancer: treatment with adriamycin, BCNU and cyclophosphamide vs. adrianycin and cyclophosphamide 116
DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study 116
Uterine leiomyosarcomas express KIT protein but lack mutation(s) in exon 9 ofc-KIT. 105
COX-2 and preoperative CA-125 level are strongly correlated with survival and clinical responsiveness to chemiotherapy in ovarian cancer. 101
Use of electronic administrative databases to measure quality indicators of breast cancer care: Experience of five regional oncology networks in Italy 101
HER-2\neu and Bcl-2 nel carcinoma ovarico: stusio clinico-patologico, immunoistochimico e molecolare in pazienti con breve e lunga sopravvivenza. 96
Correlation of in vitro drug sensitivity and clinical response in ovarian carcinoma using an ATP-luminescence tumor chemosensitivity assay 93
Management of the axilla in breast cancer patients: critical review, regional modified Delphi consensus and implementation in the Tuscan breast network 81
Indicators of the standard of care for melanoma: Tuscany data. 78
Totale 7.390
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.562
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.562
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021299 0 0 0 0 0 0 22 55 51 95 27 49
2021/2022294 13 35 15 9 11 8 18 19 9 16 69 72
2022/2023833 61 156 57 66 66 154 100 52 74 12 27 8
2023/2024334 12 32 55 24 21 29 11 87 6 19 26 12
2024/20252.081 64 198 115 294 734 304 12 104 51 65 58 82
2025/20261.210 250 286 151 136 236 96 55 0 0 0 0 0
Totale 7.390